Author

S. L. M. Arnold

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1 Microbiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Research Focus:drug response / drug discovery· 1 Research Focus:host-pathogen & immune response· 1 Organism:human· 1 Organism:mouse· 1 Assay:proteomics· 1

Frequent Co-Authors

A. Saffarian· 1 shared A.-L. B. G. Vigil· 1 shared B. G. K. Perera· 1 shared B. S. Marteyn· 1 shared C. C. Sprenger· 1 shared D. J. Maly· 1 shared G. R. Whitman· 1 shared H. H. Hogan· 1 shared

Activity by Year

2020-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 29 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperMicrobiology

A. Saffarian

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

A Compound that Inhibits Glycolysis in Prostate Cancer Controls Growth of Advanced Prostate Cancer

T. Uo, K. K. Ojo, C. C. Sprenger, K. S. Epilepsia, B. G. K. Perera, M. Damodarasamy, S. Sun, S. Kim, H. H. Hogan, M. A. Hulverson, R. Choi, G. R. Whitman, L. K. Barrett, S. A. Michaels, L. H. Xu, , S. R. Plymate

This paper evaluates a novel antiglycolytic compound, BKIDC-1553, showing selective growth inhibition of prostate cancer cells and safety for clinical trials.

bioRxiv · Jul 1, 2023Cancer Biology

IlvY is an important regulator of Shigella infection in vitro and in vivo

M. K. Holly, M. C. Anderson, L. M. Rabago, A. Saffarian, B. S. Marteyn, S. L. M. Arnold

This paper identifies IlvY as a critical regulator of Shigella virulence in vitro and in vivo using a novel oral mouse model.

bioRxiv · Jul 28, 2020 · PreprintMicrobiology